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P e n d re d sy nd ro m e is a n a u to s o m a l recessive d iso r d e r c h a ra c te riz e d b y g o ite r a n d c o n g e n ita l deafness. The p r im a r y defect is n o t yet k n o w n , a lth o u g h the gene c a u s in g P e n d re d sy n d ro m e has b e e n lo calize d very re c e n tly o n chrom osom e 7q, a re g io n th a t also c o n ta in s a gene re s p o n s ib le fo r n o n s y n d ro m a l h e a rin g loss (DFN B4). We c o n firm e d lin k a g e to th is chrom o some 7 re g io n in five P e n d re d fa m ilie s o rig in a tin g fro m d iffe re n t e th n ic g ro u p s, w ith a h ig h e st c u m u la tiv e lo d score o f 8.26 fo r m a r k e r D7S501, I n co m b in a tio n w ith p re v io u s re p o rts , o u r re s u lts define a c a n d i d ate re g io n fo r th e P e n d re d gene o f 1.7 cM flanked by m arkers D7S5G1 a n d D7S692. © 1997 A c a d e m ic P ress I N T R O D U C T IO N Pendred syndrome (MIM No. 274600) is character ized by the presence of goiter and profound congenital sensorineural hearing loss (Pendred, 1896) . Most af fected persons are euthyroid, although hypothyroidism is occasionally reported (Batsakis <?£ al., 1962), Hearing impairment is usually congenital and, in nearly all cases, is accompanied by a type of cochlear hypoplasia known as a Mondini defect (Gorlin, 1995) . The disease prevalence of Pendred syndrome is estimated at 4-10% among congenitally deaf children, and the frequency varies from 1/15,000 in the British Isles to 1/100,000 in Scandinavia (Gorlin, 1995) .
Inheritance is generally considered to be autosomal recessive, and in many families, consanguinity between nonaffected parents can be documented. However, there are some families in which the disease apparently skips generations, and the phenotype varies in affected persons. These intrafamilial differences are consistent 1 To whom correspondence should be addressed at the Department of Medical Genetics, University of Antwerp, Universiteitsplein 1 , 2610 Antwerp. Telephone; 323-8202570. Fax: 323-8202566. with autosomal dominant inheritance with incomplete penetrance (Ilium et al., 1972) .
The primary defect responsible for Pendred syn drome is not yet known, although it probably involves the partial failure to convert free iodide into organic iodine in the thyroid gland in Pendred patients (Frazer, 1965; Morgans and Trotter, 1958) . The latter process is a complex sequence of metabolic events. During the formation of thyroid hormones, iodide is first oxidized and then covalently bound to thyroglobulin (TG) to form iodotyrosyls by thyroperoxidase (TPO), The iodotyrosyls are subsequently coupled oxidatively into iodothyronines T3 and T4 within the matrix of TG (Dumont et al, 1994) . The iodine organification defect in Pen dred patients is demonstrated with the perchlorate test, which releases free iodine from the thyroid gland and is very common in patients with Pendred syndrome (Ilium et al., 1972) . TG and TPO are both major compo nents of the iodine organification system. However, bio chemical studies failed to find abnormalities in these proteins in Pendred patients (Burrow et ah, Recently, two groups reported linkage of Pendred syndrome to chromosome 7q31 in an interval of 5.5 and 9.2 cM, respectively (Coyle et al., 1996; Sheffield et al., 1996) . In the present study, we confirm the localization of the Pendred syndrome gene to 7q31, provide more evidence for genetic homogeneity, and reduce the can didate region to 1.7 cM.
MATERIALS AND METHODS
Families. The diagnosis of Pendred syndrome was established when individuals presented congenital hearing loss and a palpable goiter. In all five families an abnormal perchlorate test was present in at least one family member. Family 1 originates from Belgium and is not consanguineous (Fig 1 ) . Family 2 originates from an iso lated small village, Tasobasi, in the South of Turkey. This family is highly consanguineous and includes more then 13 affected individu als (Fig. 1) . The family has been subject of a previous clinical study (Kabakkaya et a t, 1993) . Families 3 and 4 originate from the Nether lands, and the parents of the patients are consanguineous. The two patients from Family 4 have been described extensively (Cremers, 1976) . A fifth family lives in Denmark but originates from Lebanon, Patient IV-2 from this family showed no goiter and a normal perchlo rate test, although congenital hearing loss was present, and a co chlear defect of the Mondini type was shown by CT scan. Patient IV-3 has congenital hearing loss, a Mondini malformation of the cochlea, an abnormal perchlorate test, but no goiter.
Linkage analysis. Genomic DNA was purified from peripheral blood samples by standard techniques. Microsatellite polymorphisms were taken from the recent genetic map from Genethon (Dib et a i, 1996) , Polymerase chain reaction amplification and electrophoresis on polyacrylamide gels were performed as described (Hughes, 1993) . Two-point linkage analysis was performed using the MLINK pro gram of the LINKAGE 5.1 package (Lathrop and Laouel, 1984 ). An estimated frequency of 1 /1 0 0 was used for the disease gene, and penetrance was set at 100%. Allele frequencies were set equal to each other. Lod score calculations in Family 2 were performed without the consanguinity of the parents of sibship B and of the paternal grandparents of sibship D taken into account.
RESULTS

Linkage Analysis
Five families segregating with Pendred syndrome were studied (Fig. 1) . We typed these five pedigrees with 10 polymorphic markers from 7q31. All these markers were obtained from the most recent Genethon genetic map (Fig. 2) (Dib et al., 1996) . Table 1 summa rizes the two-point lod scores for the 10 markers. Cu mulative lod scores higher than 3 were obtained for all markers except D7S523. The highest combined lod score of 8.26 was obtained for marker D7S501 at recom bination fraction 0. When the lod scores for each of the families were analyzed separately, lod scores higher than 3 were obtained only for Family 2 with a maxi mum of 4.91 for marker D7S496 at recombination frac tion 0. The other four families are too small to yield statistically significant lod scores, but the theoretical maximum lod score was approached for each of the families when the lod scores were calculated with 100% informative markers. Therefore, it is likely that all five families are linked to chromosome 7q. Statistical analy sis of the data using HOMOG (Ott, 1991) gave a maxi mum likelihood under the hypothesis of linkage homo geneity, confirming this assumption.
Uaplotype Analysis
To narrow down the candidate region of the Pendred gene, haplotypes were constructed for the 10 markers that were analyzed. As Family 2 is highly inbred, ho mozygosity mapping was used to delineate the interval containing the Pendred gene. In this family, eight .Pen dred patients from four related sibships (A-D) were analyzed (Fig. 1) . In sibship A, the parents are first cousins, and both patients are homozygous for all 10 markers tested. The parents for sibship B were re ported to be consanguineous, but the exact nature of their blood relationship could not be indicated by the family members. The three patients from sibship B are homozygous for four adjacent markers, D7S2453, D7S501, D7S496, and D7S2459. In contradiction to the consanguinity of the parents of sibship C that was re ported in a previous study (Kabakkaya et a i, 1993) , extensive interviews of the family on several occasions in the course of this study revealed no reports of con sanguinity between the parents of sibship C. As the father of this sibship has a completely different disease haplotype, he is most likely unrelated to the family and carries an independent Pendred mutation. The parents of sibship D are first cousins, and the paternal grand parents were also reported to be related by family mem bers, although they could not indicate the exact nature of this consanguinity. The patient from sibship D is homozygous for five adjacent markers, D7S2453, D7S501, D7S496, D7S2459, and D7S692. When the disease-carrying chromosome from the unrelated fa ther of sibship C is not taken into account, all the haplo types of the eight patients in Family 2 are i dentical for the four adjacent markers D7S2453, D7S501, D7S496, and D7S2459. Under the assumption that the parents of sibship B are consanguineous and have inherited the same mutation from a common ancestor, a historical recombination must have occurred between the Pen dred gene and D7S692. This assumption is likely for two reasons. First, several family members confirmed the consanguinity of the parents of sibship B. Second, the three patients of sibship B are homozygous for four adjacent markers, D7S2453, D7S501, D7S496, and D7S2459, that also show several other alleles in the rest of the family. For these reasons, it is more likely that those four adjacent markers are homozygous by descent than that they are homozygous by chance. Un der the more likely hypothesis of a single common an cestral disease chromosome, this key recombinant de fines the candidate region for the Pendred gene as an interval of 6.9 cM flanked by D7S2446 and D7S692 (Fig. 2) .
Haplotype analysis of Families 1, 3, and 4 confirms the candidate region determined in Family 2. A recom bination between D7S2446 and the Pendred gene in patient II-l from Family 1 confirms the exclusion of the region centromeric to D7S2446, whereas recombi nations with D7S523 in Families 3 and 4 confirm that the Pendred gene is located centromeric to D7S523 (Figs. 1 and 2) . 3 5 5 5 5 5 2 2 2 2 3 2 2 2 2 2 2 2 2 2 2 2 1 2 I 2 1 l 1 1 1 1 1 D7S2453  3 3  3 3  4 3  3 3  3 3  4 3  43  3 3  I 3  4 3  D7S5QI l 4 l 2 1 2 1 2 1 4 1 2 1 4 2 2 5 2 1 2 D7S496 1 2 1 5 3 5 1 5 1 2 3 5 3 2 5 5 2 5 tients and is therefore very useful for linkage analysis, yielding lod scores higher than 3 with chromosome 7 markers. The other four families, of which three are consanguineous, are much smaller. However, they are probably also linked to this region based upon the ho mozygosity in the patients of the consanguineous Fam ilies 3, 4 and 5 and the positive lod score of 0.98 for Family 1.
Combining previously reported data (Coyle et al., 1996; Sheffield et ah, 1996) with our own data, we could narrow the candidate region to 1.7 cM between mark ers D7S501 and D7S692. However, it should be noted Lebanon. Coyle et al. (1996) reported linkage in 11 fam ilies of British origin and 1 from Asia, and Sheffield et al. (1996) proved linkage in 2 families of Arab origin. There is no indication for genetic heterogeneity in any of these 19 families, although most of these families are too small to prove linkage independently. These results suggest that the locus on chromosome 7q may be the only locus for Pendred syndrome. Because only a limited number of families have been analyzed so far, additional linkage studies should be performed to prove genetic homogeneity. This is important if genetic diag nosis is requested by small families affected with the disease.
Three other hereditary diseases have been mapped to the Pendred chromosomal region: nonsyndromal au tosomal recessive deafness DFNB4 (Baldwin et al.,  1995) , cystic fibrosis (CF) (Riordan et al.} 1989) , and congenital chloride diarrhea (CLD) (Kere et ah, 1993) . The candidate regions for DFNB4 and CLD are identi cal and are bounded by flanking markers D7S501 and D7S523. Both markers were mapped a few centimorgans proximal to the CF gene (Kere et a l, 1993) . This means that the Pendred candidate region deter mined in this study is entirely located inside the candi date region of DFNB4 and CLD. To our knowledge, no genes with a known function in hearing or thyroid metabolism have been mapped to this region, which would make them obvious candidate genes for Pendred syndrome. Although CLD and Pendred syndrome prob ably map to the same region by chance, the colocaliza tion of DFNB4 and Pendred syndrome might not be coincidental. It has been shown that a single gene can be responsible for both syndromic and nonsyndromic deafness, as mutations in the myosin VILA gene give rise to Usher syndrome (Weil et a l3 1995) as well as nonsyndromal deafness (DFNB2) (Ayadi et al., 1996) . As no perchlorate test was performed in the DFNB4 family, and the size of the goiter is variable in Pendred syndrome, thyroid problems might have remained un detected in the DFNB4 family. Alternatively, it is possi ble that certain mutations in the same gene lead to a combined defect of iodine organification and deafness, while other mutations lead only to deafness. On the other hand only one of the three patients from Family 5 had all typical abnormalities of Pendred syndrome that both flanking markers are based on a single recom-(deafness, Mondini malformation, goiter, abnormal binant. The proximal flanking marker D7S501 recom bines with the Pendred gene in a patient from a small pedigree, published in a previous study (Coyle et a l, 1996) . The distal flanking marker D7S692, which comes from the analysis of Family 2 (sibship B) in this study, is based on the assumption that the parents of sibship B are consanguineous and have inherited the same mutation from a common ancestor.
Linkage of Pendred syndrome to chromosome 7q31 has been found now in 19 families from different ethnic origins. Our study includes 5 families originating from Belgium, The Netherlands (2 families), Turkey, and perchlorate test), whereas one sibling had no goiter and two siblings had a normal perchlorate test. This intrafamilial clinical variability shows that the diagno sis of Pendred syndrome can be missed and that cases might be classified as nonsyndromic deafness.
The relatively small region of 1.7 cM containing the Pendred gene will make it possible to use positional cloning techniques to isolate the Pendred gene. This will be an important step in the elucidation of the mo lecular pathology of the syndrome. The gene identifica tion will also clarify whether Pendred syndrome and DFNB4 are allelic or not and lead to a better under- 
